Novo Nordisk (NYSE:NVO) stock has experienced a significant decline, dropping 35% from over $90 in early March to around $58 currently. Several factors have contributed to this downward trend. The ...

Recent reports indicate the US economy experienced negative growth in the first quarter, creating a stark contrast with the stock market’s performance. This economic contraction comes at a time when ...

Raymond James downgrades the bank's stock by two notches, and upgrades U.S. Bancorp shares, as regional banks gain favor following big run-ups by the largest banks This story has been updated to ...

Stock prices tied to artificial intelligence companies might be climbing partly because investors are scared of missing the rally. But financial experts say now’s not the time to bail out. The ...

Procter & Gamble's growth has slowed, with weak cash flow and operational metrics not matching its earnings and sales performance. Despite its defensive profile and dividend history, current valuation ...

TXN is a Buy for risk-tolerant, dollar-cost averaging investors, with deep undervaluation and long-term upside driven by U.S. manufacturing and AI exposure. Strategic U.S. footprint, favorable tax law ...

Forbes contributors publish independent expert analyses and insights. #1 stock picker for 51 straight months on SumZero. AI is my edge. Humans have been wearing shoes for thousands of years. Today, ...

Large, publicly traded health insurers have seen stock price increases over the past 15 years, in one case exceeding 1,000%. Information that President Donald Trump appeared to be citing shows stock ...

This story has been updated to correct a misstated price target for Wells Fargo’s stock. The target price has been withdrawn and was previously $84 a share. A big rally in Wells Fargo & Co.’s stock ...